The abstract is read at the publisher; the summary is JClub's.
circ-ZNF609 is upregulated in mouse cardiac tissue, adult cardiomyocytes, and cardiac fibroblasts 4 weeks after transverse aortic constriction (TAC), and its inhibition attenuates remodeling.
- Why it matters: Effective ways to reverse cardiac remodeling in heart failure are lacking, and the study seeks actionable molecular targets and mechanisms driving the process.
- What they did: Mice received shRNA silencing of circ-ZNF609 or RNA-targeting hfCas13x-crRNA to inhibit it, including after established hypertrophy; effects were tested in cardiomyocytes and fibroblasts, with YTHDF3 and ZEB1 expression assessed.
- The result: circ-ZNF609 inhibition attenuates TAC-induced remodeling and established hypertrophy, reduces cardiomyocyte hypertrophy and fibroblast myofibroblast differentiation, and suppresses ZEB1 via YTHDF3 in an m6A-dependent manner.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.